🇩🇪 LONCASTUXIMAB TESIRINE in Germany

LONCASTUXIMAB TESIRINE (LONCASTUXIMAB TESIRINE) regulatory status in Germany.

Marketing authorisation

BfArM

  • Local brand name: Zynlonta
  • Status: approved

LONCASTUXIMAB TESIRINE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Germany

Frequently asked questions

Is LONCASTUXIMAB TESIRINE approved in Germany?

Yes. BfArM has authorised it.

Who is the marketing authorisation holder for LONCASTUXIMAB TESIRINE in Germany?

Marketing authorisation holder not available in our data.